keyword
https://read.qxmd.com/read/38545481/predictors-of-immunotherapy-efficacy-in-metastatic-non-small-cell-lung-cancer-lung-immune-prognostic-index-and-immune-related-toxicity
#21
JOURNAL ARTICLE
Alba Moratiel Pellitero, Maria Zapata Garcia, Marta Gascon Ruiz, Jose Miguel Arbones-Mainar, Rodrigo Lastra Del Prado, Dolores Isla
BACKGROUND: Immune checkpoint inhibitors (ICIs) have been proposed as the standard first-line and subsequent treatment for metastatic non-small cell lung cancer (NSCLC). This study analyzed whether patients with good lung immune prognostic index (LIPI) have a better response to ICIs and the relationship between immune-related adverse events (irAEs) and response in clinical practice. METHODS: This was an observational, retrospective, single-center study. Patients with stage IV NSCLC between 2016 and 2021 were included in the study...
April 2024: World Journal of Oncology
https://read.qxmd.com/read/38543317/intracellular-delivery-of-therapeutic-protein-via-ultrathin-layered-double-hydroxide-nanosheets
#22
JOURNAL ARTICLE
He Zhang, Anle Ge, Yulin Wang, Boran Xia, Xichu Wang, Zhonghui Zheng, Changsheng Wei, Bo Ma, Lin Zhu, Rose Amal, Sung Lai Jimmy Yun, Zi Gu
The therapeutic application of biofunctional proteins relies on their intracellular delivery, which is hindered by poor cellular uptake and transport from endosomes to cytoplasm. Herein, we constructed a two-dimensional (2D) ultrathin layered double hydroxide (LDH) nanosheet for the intracellular delivery of a cell-impermeable protein, gelonin, towards efficient and specific cancer treatment. The LDH nanosheet was synthesized via a facile method without using exfoliation agents and showed a high loading capacity of proteins (up to 182%)...
March 19, 2024: Pharmaceutics
https://read.qxmd.com/read/38540948/effects-of-viable-and-heat-inactivated-bifidobacterium-longum-d42-on-proliferation-and-apoptosis-of-ht-29-human-colon-cancer-cells
#23
JOURNAL ARTICLE
Yifan Zhang, Ting Cao, Yuqi Wang, Rui Yang, Yu Han, Shuang Li, Deyu Liu, Yingxue Yue, Yun Cao, Bailiang Li, Song Wang, Guicheng Huo
Bifidobacterium longum is a common probiotic; both viable and heat-inactivated Bifidobacterium longum have many probiotic effects, such as anticancer effects. But some mechanisms of anticancer effects are still unclear, especially for heat-inactivated probiotics. In this study, we analyzed the effects of viable and heat-inactivated Bifidobacterium longum D42 on human colon cancer cells (HT-29). Cell proliferation, membrane permeability and apoptosis were detected by using the CCK-8 method, LDH method and Annexin V-FITC/PI kits...
March 21, 2024: Foods (Basel, Switzerland)
https://read.qxmd.com/read/38520008/a-mgal-ldh-cus-nanosheet-based-thermo-responsive-composite-hydrogel-with-nir-responsive-angiogenesis-inhibitor-releasing-capability-for-multimode-starvation-therapy
#24
JOURNAL ARTICLE
Xueyan Liu, Tingting Hu, Yijiang Jia, Shuqing Yang, Yu Yang, Zhuolin Cui, Tao Wang, Ruizheng Liang, Chaoliang Tan, Yuji Wang
The rapid proliferation of tumors is highly dependent on the nutrition supply of blood vessels. Cutting off the nutrient supply to tumors is an effective strategy for cancer treatment, known as starvation therapy. Although various hydrogel-based biomaterials have been developed for starvation therapy through glucose consumption or intravascular embolization, the limitations of single-mode starvation therapy hinder their therapeutic effects. Herein, we propose a dual-function nutrition deprivation strategy that can block the nutrients delivery through extravascular gelation shrinkage and inhibit neovascularization through angiogenesis inhibitors based on a novel NIR-responsive nanocomposite hydrogel...
March 23, 2024: Journal of Nanobiotechnology
https://read.qxmd.com/read/38518533/outcome-of-adjuvant-immunotherapy-in-a-real-world-nation-wide-cohort-of-patients-with-melanoma
#25
JOURNAL ARTICLE
Rikke B Holmstroem, Sidsel Pedersen, Rebecca Jurlander, Kasper Madsen, Marco Donia, Christina H Ruhlmann, Henrik Schmidt, Charlotte A Haslund, Lars Bastholt, Inge Marie Svane, Eva Ellebaek
BACKGROUND: Clinical trials have demonstrated promising outcomes for adjuvant immunotherapy in patients with resected melanoma. Real-life data provide valuable insights to support patient guidance and treatment decisions. METHODS: Observational population-based study examining a national cohort of patients with resected stage III-IV melanoma referred for adjuvant therapy. Data were extracted from the Danish Metastatic Melanoma Database (DAMMED). RESULTS: Between November 2018 and January 2022, 785 patients received adjuvant anti-PD-1...
March 19, 2024: European Journal of Cancer
https://read.qxmd.com/read/38513927/decitabine-combined-with-cold-atmospheric-plasma-induces-pyroptosis-via-the-ros-caspase-3-gsdme-signaling-pathway-in-ovcar5-cells
#26
JOURNAL ARTICLE
Liang Du, Huiyun Ming, Zhuna Yan, Jinwu Chen, Wencheng Song, Haiming Dai
BACKGROUND: High methylation of the DFNA5 gene results in the absence of GSDME, a key protein that mediates pyroptosis, while decitabine demethylates the DFNA5 gene, resulting in high expression of the GSDME protein. Cold atmospheric plasma (CAP) is a novel anti-cancer method that induces tumor cell death. METHODS: The pyroptosis induced by decitabine in combination with CAP in Ovcar5 cells was evaluated. In particular, mitochondrial membrane potential was estimated by JC-1 staining, dehydrogenase (LDH) release was assessed by ELISA, Annexin V/PI staining was detected by flow cytometry, the cell cycle changes were evaluated using PI staining followed by detection by flow cytometry, and Caspase-9 cleavage, Caspase-3 cleavage and GSDME expression were evaluated by western blot...
March 19, 2024: Biochimica et Biophysica Acta. General Subjects
https://read.qxmd.com/read/38508620/rituximab-combined-anthracycline-free-chemotherapy-in-newly-diagnosed-paediatric-and-adolescent-patients-with-non-high-risk-aggressive-mature-b-cell-lymphoma-protocol-for-a-single-arm-open-label-multicentre-phase-ii-study-the-japan-children-s-cancer-group-multicentre
#27
JOURNAL ARTICLE
Masahiro Sekimizu, Reiji Fukano, Yuhki Koga, Tetsuo Mitsui, Naoto Fujita, Takeshi Mori, Daiki Hori, Makito Tanaka, Kentaro Ohki, Hideto Iwafuchi, Atsuko Nakazawa, Tetsuya Mori, Ryoji Kobayashi, Hiroya Hashimoto, Akiko M Saito, Michi Kamei
INTRODUCTION: Children and adolescents with mature B cell non-Hodgkin lymphoma (B-NHL) are treated with short-intensive chemotherapy. The burden of short-term and long-term toxicity is highly relative to its high cure rate in good-risk patients. Although the addition of rituximab to standard lymphome Malin B (LMB) chemotherapy markedly prolongs event-free survival and overall survival in high-risk patients, the benefit of rituximab in good-risk patients remains to be elucidated. This clinical trial will examine whether the addition of rituximab eliminates anthracyclines in good-risk patients without compromising treatment outcomes...
March 19, 2024: BMJ Open
https://read.qxmd.com/read/38501901/layered-double-hydroxides-recent-progress-and-promising-perspectives-toward-biomedical-applications
#28
REVIEW
Lei Li, Irem Soyhan, Eliza Warszawik, Patrick van Rijn
Layered double hydroxides (LDHs) have been widely studied for biomedical applications due to their excellent properties, such as good biocompatibility, degradability, interlayer ion exchangeability, high loading capacity, pH-responsive release, and large specific surface area. Furthermore, the flexibility in the structural composition and ease of surface modification of LDHs makes it possible to develop specifically functionalized LDHs to meet the needs of different applications. In this review, the recent advances of LDHs for biomedical applications, which include LDH-based drug delivery systems, LDHs for cancer diagnosis and therapy, tissue engineering, coatings, functional membranes, and biosensors, are comprehensively discussed...
March 19, 2024: Advanced Science (Weinheim, Baden-Wurttemberg, Germany)
https://read.qxmd.com/read/38501833/advances-of-layered-double-hydroxide-based-materials-for-tumor-imaging-and-therapy
#29
REVIEW
Ke Ma, Ke-Zheng Chen, Sheng-Lin Qiao
Layered double hydroxides (LDH) are a class of functional anionic clays that typically consist of orthorhombic arrays of metal hydroxides with anions sandwiched between the layers. Due to their unique properties, including high chemical stability, good biocompatibility, controlled drug loading, and enhanced drug bioavailability, LDHs have many potential applications in the medical field. Especially in the fields of bioimaging and tumor therapy. This paper reviews the research progress of LDHs and their nanocomposites in the field of tumor imaging and therapy...
March 19, 2024: Chemical Record: An Official Publication of the Chemical Society of Japan ... [et Al.]
https://read.qxmd.com/read/38501405/-efficacy-of-combined-treatment-with-pirfenidone-and-pd-l1-inhibitor-in-mice-bearing-ectopic-bladder-cancer-xenograft
#30
JOURNAL ARTICLE
S Chen, S Zhang, W Fan, W Sun, B Liu, J Liu, Y Guo
OBJECTIVE: To assess the efficacy of pirfenidone combined with PD-L1 inhibitor for treatment of bladder cancer in a mouse model and its effect on tumor immune microenvironment modulation. METHODS: Forty C57BL/6 mouse models bearing ectopic human bladder cancer xenografts were randomized into control group, PD-L1 inhibitor group, pirfenidone group and combined treatment group ( n =10). After successful modeling, PD-L1 inhibitor treatment was administered via intraperitoneal injection at 12...
February 20, 2024: Nan Fang Yi Ke da Xue Xue Bao, Journal of Southern Medical University
https://read.qxmd.com/read/38494270/phytocompounds-based-therapeutic-approach-investigating-curcumin-and-green-tea-extracts-on-mcf-7-breast-cancer-cell-line
#31
JOURNAL ARTICLE
Radwa M Fawzy, Amal A Abdel-Aziz, Khalid Bassiouny, Aysam M Fayed
BACKGROUND: Breast cancer (BC) has transcended lung cancer as the most common cancer in the world. Due to the disease's aggressiveness, rapid growth, and heterogeneity, it is crucial to investigate different therapeutic approaches for treatment. According to the World Health Organization (WHO), Plant-based therapeutics continue to be utilized as safe/non-toxic complementary or alternative treatments for cancer, even in developed countries, regardless of how cutting-edge conventional therapies are...
March 2024: Journal, Genetic Engineering & Biotechnology
https://read.qxmd.com/read/38491825/the-outcome-in-patients-with-braf-mutated-metastatic-melanoma-treated-with-anti-programmed-death-receptor-1-monotherapy-or-targeted-therapy-in-the-real-world-setting
#32
JOURNAL ARTICLE
Jindřich Kopecký, Marek Pásek, Radek Lakomý, Bohuslav Melichar, Ivona Mrazová, Ondřej Kubeček, Monika Arenbergerová, Radmila Lemstrová, Alžběta Švancarová, Vojtěch Tretera, Alžběta Hlodáková, Kamila Žváčková
BACKGROUND: Immunotherapy and targeted therapy are currently two alternative backbones in the therapy of BRAF-mutated malignant melanoma. However, predictive biomarkers that would help with treatment selection are lacking. METHODS: This retrospective study investigated outcomes of anti-programmed death receptor-1 monotherapy and targeted therapy in the first-line setting in patients with metastatic BRAF-mutated melanoma, focusing on clinical and laboratory parameters associated with treatment outcome...
March 2024: Cancer Medicine
https://read.qxmd.com/read/38486724/study-on-the-correlation-between-controlling-nutritional-status-score-and-clinical-biochemical-indicators-in-patients-with-colorectal-cancer
#33
JOURNAL ARTICLE
Zhi Wang, Jin Bian, Jiayan Yuan, Sunyan Zhao, Shijia Huang, Rong Wu, Fei Fei
PURPOSE: The controlling nutritional status (CONUT) score is an important tool for predicting the prognosis of colorectal cancer (CRC); however, its effectiveness is relatively insufficient. This study aimed to screen for more effective clinical indicators as supplements to the CONUT scoring system and improve the predictive value of CRC prognosis. PATIENTS AND METHODS: Between 2014 and 2020, the clinical information of all CRC patients in our unit was retrospectively collected, and the CONUT scores were calculated based on the levels of serum albumin (ALB), lymphocytes (LC), and total cholesterol...
March 15, 2024: Heliyon
https://read.qxmd.com/read/38473882/salivary-biomarkers-for-oral-cancer-detection-an-exploratory-systematic-review
#34
REVIEW
Daniel Bastías, Alejandro Maturana, Constanza Marín, René Martínez, Sven Eric Niklander
Different efforts have been made to find better and less invasive methods for the diagnosis and prediction of oral cancer, such as the study of saliva as a source of biomarkers. The aim of this study was to perform a scoping review about salivary molecules that have been assessed as possible biomarkers for the diagnosis of oral squamous cell carcinoma (OSCC). A search was conducted using EBSCO, PubMed (MEDLINE), Scopus, and Web of Science. The research question was as follows: which molecules present in saliva have utility to be used as biomarkers for the early detection of oral cancer? Sixty-two studies were included...
February 23, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38473398/dual-checkpoint-aptamer-immunotherapy-unveiling-tailored-cancer-treatment-targeting-ctla-4-and-nkg2a
#35
JOURNAL ARTICLE
Mohamad Ammar Ayass, Trivendra Tripathi, Natalya Griko, Tutku Okyay, Ramya Ramankutty Nair, Jin Zhang, Kevin Zhu, Kristen Melendez, Victor Pashkov, Lina Abi-Mosleh
Recent strides in immunotherapy have illuminated the crucial role of CTLA-4 and PD-1/PD-L1 pathways in contemporary oncology, presenting both promises and challenges in response rates and adverse effects. This study employs a computational biology tool (in silico approach) to craft aptamers capable of binding to dual receptors, namely, inhibitory CTLA4 and NKG2A, thereby unleashing both T and NK cells and enhancing CD8+ T and NK cell functions for tumor cell lysis. Computational analysis highlighted AYA22T-R2-13 with HADDOCK scores of -78...
March 4, 2024: Cancers
https://read.qxmd.com/read/38473216/real-world-data-on-clinical-outcomes-and-treatment-management-of-advanced-melanoma-patients-single-center-study-of-a-tertiary-cancer-center-in-switzerland
#36
JOURNAL ARTICLE
Ramon Staeger, Julia M Martínez-Gómez, Patrick Turko, Egle Ramelyte, Lukas Kraehenbuehl, Valerio Del Prete, Omar Hasan Ali, Mitchell P Levesque, Reinhard Dummer, Mirjam C Nägeli, Joanna Mangana
BACKGROUND: Immune checkpoint inhibitors (ICIs) and BRAF/MEK inhibitors (BRAF/MEKi) have drastically changed the outcomes of advanced melanoma patients in both the resectable/adjuvant and unresectable/metastatic setting. In this follow-up analysis of real-world data, we aimed to investigate the clinical management and outcomes of advanced melanoma patients in a tertiary referral center in Switzerland approximately a decade after the introduction of ICIs and BRAF/MEKi into clinical use...
February 20, 2024: Cancers
https://read.qxmd.com/read/38466133/c-reactive-protein-flare-predicts-response-to-checkpoint-inhibitor-treatment-in-melanoma
#37
JOURNAL ARTICLE
Julian Kött, Noah Zimmermann, Tim Zell, Isabel Heidrich, Glenn Geidel, Alessandra Rünger, Daniel J Smit, Myriam Merkle, Niousha Parnian, Inga Hansen, Inka Hoehne, Finn Abeck, Leopold Torster, Michael Weichenthal, Klaus Pantel, Stefan W Schneider, Christoffer Gebhardt
BACKGROUND: The treatment of melanoma has been revolutionized by the use of immune checkpoint inhibition (ICI), but many patients do not benefit. Furthermore, immune-related adverse events may occur during therapy. A predictive biomarker is needed to reliably identify patients benefitting. In lung, renal cell and bladder cancer early C-reactive protein (CRP) kinetics were shown to be a predictive biomarker for ICI. OBJECTIVE: Here, we investigate early CRP kinetics as predictive biomarker for ICI in melanoma patients...
March 11, 2024: Journal of the European Academy of Dermatology and Venereology: JEADV
https://read.qxmd.com/read/38460301/the-activation-of-the-aim2-inflammasome-after-cigarette-smoke-exposure-leads-to-an-immunosuppressive-lung-microenvironment
#38
JOURNAL ARTICLE
Chiara Colarusso, Anna Falanga, Simone Di Caprio, Michela Terlizzi, Aldo Pinto, Piera Maiolino, Rosalinda Sorrentino
Cigarette smoke is widely known as contributing to chronic inflammation underlying several airway diseases, such as chronic obstructive pulmonary disease (COPD) and lung cancer. In our previous studies we found that the lung of both COPD and cancer patients were characterized by the presence and activation of the AIM2 inflammasome. Here, we wanted to investigate the upstream step during the establishment of chronic lung inflammation after cigarette smoke exposure. We took advantage of a mouse model of smoking exposure and public scRNAseq data...
March 8, 2024: International Immunopharmacology
https://read.qxmd.com/read/38459728/resveratrol-nanoformulation-inhibits-invasive-breast-cancer-cell-growth-through-autophagy-induction-an-in-vitro-study
#39
JOURNAL ARTICLE
Mohammad Rasool Khazaei, Maryam Bozorgi, Mozafar Khazaei, Maryam Aftabi, Azam Bozorgi
OBJECTIVE: The aim of this study was to synthesize chitosan nanoparticles (Cs NPs) for resveratrol (RSV) delivery and assess their effectiveness in inducing autophagy in MDA-MB 231 cells. MATERIALS AND METHODS: In this experimental study, Pure and RSV-loaded Cs NPs (RSV. Cs NPs) were prepared via the ionic gelation method, and their physicochemical properties were characterized using standard techniques, and RSV release was measured in vitro . MDA-MB 231 cells were incubated with RSV, Cs NPs, and RSV...
February 1, 2024: Cell Journal
https://read.qxmd.com/read/38451840/the-relationship-between-clinical-and-pathological-findings-and-fdg-pet-uptake-in-metastatic-colorectal-cancers
#40
JOURNAL ARTICLE
Bediz Kurt İnci, Fatih Gürler, Osman Sütcüoğlu, Gözde Tahtacı, Aytuğ Üner, Ahmet Özet, Nazan Günel, Ozan Yazıcı
BACKGROUND: In metastatic colorectal cancer (mCRC), the genetic structure and cell metabolism of the primary tumor lesion might be different from metastatic lesions. It is thought that cell-level glucose metabolism may differ due to the difference in RAS wild and mutant mCRC patients' prognosis. In this study, we aimed to compare 2-deoxy-2-[fluorine-18]-fluoro-D-glucose Positron Emission Tomography (18F-FDG PET/CT) uptake levels for KRAS mutation status and primary-metastatic tumor localization...
March 1, 2024: Indian Journal of Cancer
keyword
keyword
107582
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.